Your browser doesn't support javascript.
loading
Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer.
Zhang, Xiangyang; Wang, Min; Feng, Junyi; Qin, Bin; Zhang, Chenglin; Zhu, Chengshen; Liu, Wentao; Wang, Yaohe; Liu, Wei; Huang, Lei; Lu, Shuangshuang; Wang, Zhimin.
Afiliação
  • Zhang X; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang M; School of Material Science and Engineering, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Feng J; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Qin B; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Zhang C; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Zhu C; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Liu W; School of Material Science and Engineering, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang Y; School of Material Science and Engineering, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Liu W; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Huang L; Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Lu S; Inflammations Immunity Research Theme, Translational and Clinical Research Institute, FMS, Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK.
  • Wang Z; Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
J Nanobiotechnology ; 20(1): 166, 2022 Mar 28.
Article em En | MEDLINE | ID: mdl-35346194
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Nanopartículas Multifuncionais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Nanopartículas Multifuncionais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article